MAP1LC3B and laryngeal carcinoma: Additionally, immunohistochemistry (IHC) confirmed that the levels of IL6 and LC3b in the CTSL‐knockdown group were significantly lower than those in the control group, further suggesting that CTSL promotes laryngeal cancer autophagy through the IL6‐JAK‐STAT3 signalling pathway (Figure 6D).